Cargando…

The diagnostic and prognostic value of growth differentiation factor‐15 in systemic lupus erythematosus‐associated pulmonary arterial hypertension

Growth‐differentiation factor (GDF)‐15 is a member of transforming growth factor‐β‐related cytokine and may respond to right ventricular overload. The objective of this article was to assess the diagnosis and prognostic value of GDF‐15 in systemic lupus erythematosus‐associated pulmonary arterial hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Junyan, Ding, Yufang, Yang, Xiaoxi, Wang, Qian, Zhao, Jiuliang, Liu, Yongtai, Tian, Zhuang, Wang, Yanhong, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912020/ https://www.ncbi.nlm.nih.gov/pubmed/36788942 http://dx.doi.org/10.1002/pul2.12195

Ejemplares similares

Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
por: Huang, Can, et al.
Publicado: (2016)

Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
por: Qu, Jingge, et al.
Publicado: (2021)

A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Qu, Jingge, et al.
Publicado: (2023)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022)

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis
por: Peng, Liying, et al.
Publicado: (2020)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
por: You, Hanxiao, et al.
Publicado: (2020)

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China: A Systemic Review of Observational Studies
por: Wang, Ziqian, et al.
Publicado: (2015)

Exploring the risk factors and prognosis of transverse myelitis in systemic lupus erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry
por: Wang, Haiyan, et al.
Publicado: (2023)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
por: Xiang, Yirong, et al.
Publicado: (2021)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)

Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
por: Yang, Yanli, et al.
Publicado: (2021)

Quality of life in ambulatory pulmonary arterial hypertension in connective tissue diseases and its relationship with risk stratification
por: Shi, Yue, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus
por: Qiao, Lin, et al.
Publicado: (2022)

Characteristics and Long-term Outcomes of Patients with Lupus-related Protein-losing Enteropathy: A Retrospective Study
por: Peng, Liying, et al.
Publicado: (2020)

Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China
por: Zhang, Shangzhu, et al.
Publicado: (2021)

Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification
por: Shi, Yue, et al.
Publicado: (2022)

Improve quality of patient care for systemic lupus erythematosus in China by enhancing the construction of Centers of Excellence
por: Li, Mengtao, et al.
Publicado: (2023)

Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus
por: Xu, Dong, et al.
Publicado: (2015)

Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry
por: Wang, Ziqian, et al.
Publicado: (2021)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
por: Dong, Xingbei, et al.
Publicado: (2022)

Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
por: You, Hanxiao, et al.
Publicado: (2023)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Clinical Analysis of 61 Systemic Lupus Erythematosus Patients With Intestinal Pseudo-Obstruction and/or Ureterohydronephrosis: A Retrospective Observational Study
por: Xu, Na, et al.
Publicado: (2015)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
por: Gui, Yinli, et al.
Publicado: (2022)

Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus
por: Li, Jing, et al.
Publicado: (2014)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
por: Shi, Yue, et al.
Publicado: (2022)

Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
por: Cheng, Cheng, et al.
Publicado: (2023)

The Coexistence of Systemic Lupus Erythematosus and Thyrotoxicosis: The Diagnostic Value of Antihistone Antibodies
por: Baleva, Marta, et al.
Publicado: (2012)

Identification of 6 dermatomyositis subgroups using principal component analysis‐based cluster analysis
por: Zhu, Huiyi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3co4dceam122uv5r9962f0tivm